Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Jan;27(1):55–62.

Confounding factors in HLA-DW 2 typing of human leucocytes.

B Källén, B Löw, O Nilsson
PMCID: PMC1540907  PMID: 139221

Abstract

Three healthy HLA-B7 homozygous subjects were found with similar but not identical HLA-D antigens; one was DW 2 homozygous according to independent typing results. This could be an expression of "long" and "short" HLA-D antigens or be due to differences in weak antigens outside the HLA-D region. Two further healthy HLA-B7 homozygous subjects were studied; one was apparently heterozygous for DW 2, the other apparently carried no DW 2 antigen. Both could discriminate between different DW 2 homozygous test cells. Two such test cells--one from a patient with multiple sclerosis (MS) and the other from a man with two children with MS--gave variable and absurb reactions with cells from the two subjects in question. It is tentatively suggested that genes exist which, when present in both moities in a mixed leucocyte reaction (MLR), can impair the MLR and give false "typing" reactions. This might be more common among patients with MS and perhaps also some other diseases (certain arthritides, e.g. rheumatoid arthritis) than among healthy subjects and can complicate or make impossible the interpretation of HLA-D typing data. It could also explain the previously-described impaired MLR between cells from patients with these diseases.

Full text

PDF
55

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Astorga G. P., Williams R. C., Jr Altered reactivity in mixed lymphocyte culture of lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1969 Dec;12(6):547–554. doi: 10.1002/art.1780120602. [DOI] [PubMed] [Google Scholar]
  2. Cazzullo C. L., Smeraldi E. Multiple sclerosis immunogenetics: a) associations between HL-A antigens and high measles antibody levels. b) existence of common MLR/immune response determinants in MS patients. Boll Ist Sieroter Milan. 1974;53(5):615–624. [PubMed] [Google Scholar]
  3. Dupont B., Jersild C., Hansen G. S., Nielsen L. S., Thomsen M., Svejgaard A. Multiple MLC (LD) determinants on the same HL-A haplotype. Transplant Proc. 1973 Dec;5(4):1481–1487. [PubMed] [Google Scholar]
  4. Fu S. M., Stern R., Kunkel H. G., Dupont B., Hansen J. A., Day N. K., Good R. A., Jersild C., Fotino M. Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families. J Exp Med. 1975 Aug 1;142(2):495–506. doi: 10.1084/jem.142.2.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hedberg H., Källén B., Löw B., Nilsson O. Further studies on the mixed leukocyte reaction in multiple sclerosis and various arthritides. Scand J Immunol. 1973;2(3):291–297. doi: 10.1111/j.1365-3083.1973.tb02038.x. [DOI] [PubMed] [Google Scholar]
  6. Hedberg H., Källén B., Löw B., Nilsson O. Impaired mixed leucocyte reaction in some different diseases, notably multiple sclerosis and various arthritides. Clin Exp Immunol. 1971 Aug;9(2):201–207. [PMC free article] [PubMed] [Google Scholar]
  7. Jersild C., Dupont B., Fog T., Platz P. J., Svejgaard A. Histocompatibility determinants in multiple sclerosis. Transplant Rev. 1975;22:148–163. doi: 10.1111/j.1600-065x.1975.tb01556.x. [DOI] [PubMed] [Google Scholar]
  8. Jersild C., Fog T., Hansen G. S., Thomsen M., Svejgaard A., Dupont B. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet. 1973 Dec 1;2(7840):1221–1225. doi: 10.1016/s0140-6736(73)90970-7. [DOI] [PubMed] [Google Scholar]
  9. Kovithavongs T., Hyska L., McConnachie P. R., Dossetor J. B. Serotyping for MLC gene products: I. Presumptive evidence that ABCIL may detect MLC factors. Tissue Antigens. 1975 Apr;5(3):165–172. doi: 10.1111/j.1399-0039.1975.tb01211.x. [DOI] [PubMed] [Google Scholar]
  10. Källén B., Löw B., Nilsson O. Mixed leukocyte reaction and hl-a specificity at multiple sclerosis. Acta Neurol Scand. 1975 Mar;51(3):184–192. doi: 10.1111/j.1600-0404.1975.tb07599.x. [DOI] [PubMed] [Google Scholar]
  11. Platz P., Dupont B., Fog T., Ryder L., Thomsen M., Svejgaard A., Jersild C. Mixed lymphocyte culture determinants, measles infection and multiple sclerosis. Proc R Soc Med. 1974 Nov;67(11):1133–1136. doi: 10.1177/003591577406701119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rood J. J., Hooff J. P., Keuning J. J. Disease predisposition, immune responsiveness and the fine structure of the HL-A supergene. A need for a reappraisal. Transplant Rev. 1975;22:75–104. doi: 10.1111/j.1600-065x.1975.tb01552.x. [DOI] [PubMed] [Google Scholar]
  13. Stastny P. Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest. 1976 May;57(5):1148–1157. doi: 10.1172/JCI108382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Svejgaard A., Platz P., Ryder L. P., Nielsen L. S., Thomsen M. HL-A and disease associations--a survey. Transplant Rev. 1975;22:3–43. doi: 10.1111/j.1600-065x.1975.tb01550.x. [DOI] [PubMed] [Google Scholar]
  15. Thomsen M., Platz P., Andersen O. O., Christy M., Lyngsøoe, Nerup J., Rasmussen K., Ryder L. P., Nielsen L. S., Svejgaard A. MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev. 1975;22:125–147. doi: 10.1111/j.1600-065x.1975.tb01555.x. [DOI] [PubMed] [Google Scholar]
  16. Thorsby E., Helgesen A., Rankin B., Möller E., Kaakinen A. Identification of five lymphocyte activating determinants in man. Tissue Antigens. 1975 Sep;6(3):147–160. doi: 10.1111/j.1399-0039.1975.tb00628.x. [DOI] [PubMed] [Google Scholar]
  17. Winchester R., Ebers G., Fu S. M., Espinosa L., Zabriskie J., Kunkel H. G. B-cell alloantigen Ag 7a in multiple sclerosis. Lancet. 1975 Oct 25;2(7939):814–814. doi: 10.1016/s0140-6736(75)80033-x. [DOI] [PubMed] [Google Scholar]
  18. Yunis E. J., Plate J. M., Ward F. E., Seigler H. F., Amos D. B. Anomalous MLR responsiveness among siblings. Transplant Proc. 1971 Mar;3(1):118–120. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES